» Articles » PMID: 25791449

Design, Synthesis, Optimization and Antiviral Activity of a Class of Hybrid Dengue Virus E Protein Inhibitors

Overview
Specialty Biochemistry
Date 2015 Mar 21
PMID 25791449
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

The β-OG pocket is a cavity in the flavivirus envelope (E) protein that was identified by Proc. Natl. Acad. Sci. U.S.A.2003, 100, 6986 as a promising site for the design of antiviral agents that interfere with virus entry into the host cell. The availability of the X-ray crystal structure of the dengue virus (DENV) E protein provided an opportunity for in silico drug design efforts to identify candidate inhibitors. The present study was set up to explore whether it is possible to generate a novel class of molecules that are hybrids between two hit compounds that have been reported previously by ACS. Chem. Biol.2008, 3, 765 following an in silico screening effort against the DENV E protein. First, a library of twenty hybrid molecules were designed and synthesized to explore the feasibility of this strategy. Antiviral evaluation in a virus-cell-based assay for DENV proved this approach to be successful, after which another twenty-four molecules were produced to further explore and optimize the potency of this novel class of hybrid inhibitors. In the end, a molecule was obtained with an EC50 against dengue virus serotype 2 in the low micromolar range (23, 1.32±0.41μM).

Citing Articles

Novel ethyl 2-hydrazineylidenethiazolidin-5-ylidene acetate clubbed with coumarinylthiazolyl pyrazole system as potential VEGFR-2 inhibitors and apoptosis inducer: synthesis, cytotoxic evaluation, cell cycle, autophagy, ADMET and molecular docking....

Bawazir W, Ali T, Alsolimani A, Assiri M, Shati A, Alfaifi M RSC Adv. 2025; 15(7):4829-4846.

PMID: 39957832 PMC: 11822769. DOI: 10.1039/d5ra00250h.


Development in the Synthesis of Bioactive Thiazole-Based Heterocyclic Hybrids Utilizing Phenacyl Bromide.

Kumari G, Dhillon S, Rani P, Chahal M, Aneja D, Kinger M ACS Omega. 2024; 9(17):18709-18746.

PMID: 38708256 PMC: 11064039. DOI: 10.1021/acsomega.3c10299.


Exploring the Targets of Dengue Virus and Designs of Potential Inhibitors.

Nath S, Malakar P, Biswas B, Das S, Sabnam N, Nandi S Comb Chem High Throughput Screen. 2023; 27(17):2485-2524.

PMID: 37962048 DOI: 10.2174/0113862073247689231030153054.


Development in the Inhibition of Dengue Proteases as Drug Targets.

Akram M, Hameed S, Hassan A, Khan K Curr Med Chem. 2023; 31(16):2195-2233.

PMID: 37723635 DOI: 10.2174/0929867331666230918110144.


Glycyrrhizic Acid Derivatives Bearing Amino Acid Residues in the Carbohydrate Part as Dengue Virus E Protein Inhibitors: Synthesis and Antiviral Activity.

Hour M, Chen Y, Lin C, Baltina L, Kan J, Tsai Y Int J Mol Sci. 2022; 23(18).

PMID: 36142222 PMC: 9499324. DOI: 10.3390/ijms231810309.